23/05/2023

EuropaBio: Biomanufacturing and pharma legislation in the spotlight at the BIO International Convention 2023

Brussels, May 2023 – EuropaBio flies the flag for European biotechnology at the highly anticipated BIO International Convention 2023, scheduled to take place in Boston, MA on 5-8 June and one of the largest biotech industry events worldwide with 100+ interactive sessions across 4 days covering all aspects of business, policy, trade and science.
23/05/2023

EUBA position on the European Commission’s Proposal for a Revised Packaging and Packaging Waste Regulation

The European Bioeconomy Alliance (EUBA)*, representing 14 leading European organisations from various sectors active in the bioeconomy, supports the intentions of the Commission’s proposal for a revised Regulation on Packaging and Packaging Waste (PPWR)1 to make all packaging reusable and recyclable by 2030. EUBA considers the move towards a circular economy essential and calls for a stronger support of the bioeconomy sector in the Commission’s legislative proposal to deliver on the sustainability and climate goals set out in the EU Green Deal.
10/05/2023

Policy Proposal for New Genomic Techniques – Joint Letter to EU Vice-President Frans Timmermans and EU Commissioners Stella Kyriakides and Janusz Wojciechowski

EuropaBio, together with 20 agri-food value chain associations, co-signed a joint letter to the European Commission, reiterating their support of the Commission’s plans for a legislative proposal on plants obtained by New Genomic Techniques (NGTs) and call for an enabling and proportionate regulatory framework.
04/05/2023

What do EuropaBio Members recommend for successful biomanufacturing in Europe?

On 27th April, EuropaBio organised a webinar to follow-up on the Biomanufacturing Policy Summit and officially release the policy recommendations resulting from the summit discussions and post-analysis. The outcome was a set of 10 policy recommendations that will be further developed by EuropaBio and shared in due course with policymakers and wider audience.